MilliporeSigma expands ADC manufacturing, EU fines Teva, AZ exec under investigation in China [The good, the bad, the ugly]
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — MilliporeSigma expands ADC manufacturing
The bad — EU fines Teva
The ugly — AZ exec under investigation
Information
- Show
- FrequencyUpdated Biweekly
- PublishedNovember 6, 2024 at 12:36 PM UTC
- Length3 min
- Episode68
- RatingClean